These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19061660)

  • 1. [Porphyria cutanea tarda in a patient presenting hepatitis C treated with imatinib].
    Chraïbi R; Labeille B; Perrot JL; Cambazard F
    Ann Dermatol Venereol; 2008 Nov; 135(11):775-6. PubMed ID: 19061660
    [No Abstract]   [Full Text] [Related]  

  • 2. Reactivation of porphyria cutanea tarda as a possible side effect of Imatinib at high dosage in chronic myeloid leukemia.
    Breccia M; Latagliata R; Carmosino I; Mandelli F; Alimena G
    Leukemia; 2004 Jan; 18(1):182. PubMed ID: 14574325
    [No Abstract]   [Full Text] [Related]  

  • 3. Imatinib mesylate-induced pseudoporphyria.
    Berghoff AT; English JC
    J Am Acad Dermatol; 2010 Jul; 63(1):e14-6. PubMed ID: 20542169
    [No Abstract]   [Full Text] [Related]  

  • 4. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
    Linde Y; Harper P; Floderus Y; Ros AM
    Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porphyria cutanea tarda, dermatomyositis and non-Hodgkin lymphoma in virus C infection.
    Bauzá A; España A; Lloret P
    Eur J Dermatol; 2003; 13(3):302-4. PubMed ID: 12804996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible sensorineural hearing loss due to Imatinib.
    Attili VS; Bapsy PP; Anupama G; Lokanatha D
    Leuk Res; 2008 Jun; 32(6):991-2. PubMed ID: 18221994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Porphyria cutanea tarda and chronic hepatitis C. Course after interferon therapy].
    Grasset D; Nougué J; Seigneuric C; Landreaud M; Voigt JJ
    Gastroenterol Clin Biol; 1994; 18(12):1148-9. PubMed ID: 7750693
    [No Abstract]   [Full Text] [Related]  

  • 8. [Infection with hepatitis C virus in porphyria cutanea tarda].
    Lima J; Serejo F; Gloria H; Ramalho F; Moura MC
    Acta Med Port; 1996; 9(7-9):283-6. PubMed ID: 9005712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe pruritus after completing pegylated interferon for hepatitis C.
    Hoffman CJ; Ray SC
    AIDS Read; 2008 Nov; 18(11):562-5. PubMed ID: 19062400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive calcifications of the scalp in a patient with porphyria cutanea tarda secondary to hepatitis C virus infection.
    Rey J; Hesse S; Bonerandi JJ
    J Eur Acad Dermatol Venereol; 2007 Feb; 21(2):286-7. PubMed ID: 17243990
    [No Abstract]   [Full Text] [Related]  

  • 11. Loss of skin pigment caused by imatinib therapy.
    McPartlin S; Leach M
    Br J Haematol; 2005 May; 129(4):448. PubMed ID: 15877727
    [No Abstract]   [Full Text] [Related]  

  • 12. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate.
    Scheinfeld N
    J Drugs Dermatol; 2006 Mar; 5(3):228-31. PubMed ID: 16573254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib-induced tumor lysis syndrome: report of a case and review of the literature.
    Chang H; Shih LY
    Chang Gung Med J; 2008; 31(5):510-4. PubMed ID: 19097599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib mesylate-induced maculopapular drug rash.
    Dogra S; Kanwar AJ
    Natl Med J India; 2003; 16(5):285-6. PubMed ID: 14680290
    [No Abstract]   [Full Text] [Related]  

  • 15. Porphyria cutanea tarda remission.
    Siegel LB; Eber BB
    Ann Intern Med; 1994 Aug; 121(4):308-9. PubMed ID: 7913592
    [No Abstract]   [Full Text] [Related]  

  • 16. Porphyria cutanea tarda in a patient with hairy cell leukemia.
    Hacker SM; Berkwitz M; Cody R
    Cutis; 1993 Apr; 51(4):251-2. PubMed ID: 8097460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine kinase inhibitors and gut toxicity: a new era in supportive care.
    Keefe D; Anthony L
    Curr Opin Support Palliat Care; 2008 Mar; 2(1):19-21. PubMed ID: 18685389
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute porphyria and indinavir].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2001 Feb; 128(2):184. PubMed ID: 11275609
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia.
    Al-Kali A; Farooq S; Tfayli A
    J Clin Pharm Ther; 2009 Oct; 34(5):607-10. PubMed ID: 19744017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligospermia in a patient receiving imatinib therapy for the hypereosinophilic syndrome.
    Seshadri T; Seymour JF; McArthur GA
    N Engl J Med; 2004 Nov; 351(20):2134-5. PubMed ID: 15537917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.